Archivos De La Sociedad Espanola De Oftalmologia最新文献

筛选
英文 中文
Permetrina tópica al 5% como tratamiento para pacientes pediátricos con phthiriasis palpebrarum: a propósito de un caso 5%外用氯菊酯用于治疗小儿手帕虫病:以一个病例为例
Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-08-01 DOI: 10.1016/j.oftal.2025.02.007
J. Noguera Campos, S. Pose Bazarra, N. Castro Casal, A. Urbano Bueno, M.D. Álvarez Díaz
{"title":"Permetrina tópica al 5% como tratamiento para pacientes pediátricos con phthiriasis palpebrarum: a propósito de un caso","authors":"J. Noguera Campos,&nbsp;S. Pose Bazarra,&nbsp;N. Castro Casal,&nbsp;A. Urbano Bueno,&nbsp;M.D. Álvarez Díaz","doi":"10.1016/j.oftal.2025.02.007","DOIUrl":"10.1016/j.oftal.2025.02.007","url":null,"abstract":"<div><div>Phthiriasis palpebrarum is defined as the involvement of the eyelids by the <em>Phthirus pubis</em> parasite. It is a pathology considered as a sexually transmitted disease, whose treatment can be challenging in some situations. We present the case of a 4-year-old patient with eyelashes severely affected by this parasite, who cooperated poorly for mechanical removal. Given this situation, we decided to prescribe a single dose of topical permethrin 5% and several applications of vaseline, repeating this treatment a week later, which led to the complete resolution of the condition. This case introduces topical permethrin 5% as an effective, safe and widely available option for the treatment of this pathology, especially for pediatric patients or those who do not cooperate adequately for mechanical removal of the parasites.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 8","pages":"Pages 481-484"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microcoria congénita: descripción de 3 casos en una familia 先天性小麻疹:一个家庭中3例的描述
Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-08-01 DOI: 10.1016/j.oftal.2025.03.003
P. Merino, A. Fuentes, P. Gómez de Liaño, J. Ruiz
{"title":"Microcoria congénita: descripción de 3 casos en una familia","authors":"P. Merino,&nbsp;A. Fuentes,&nbsp;P. Gómez de Liaño,&nbsp;J. Ruiz","doi":"10.1016/j.oftal.2025.03.003","DOIUrl":"10.1016/j.oftal.2025.03.003","url":null,"abstract":"<div><div>Congenital microcoria is a rare ocular anomaly characterized by pupil smaller than 2<!--> <!-->mm with no response to mydriatic agents. It can present in 2 forms: autosomal recessive associated with Pierson syndrome and autosomal dominant isolated (associated with a high incidence of myopia and glaucoma). Studies have identified deletions in the 13q32.1 region of chromosome 13 that include the GPR180 gene, involved in smooth muscle cell growth, as the underlying cause in autosomal dominant cases. We describe 3 members of a family with deletion of the GPR180 gene on chromosome 13. In all, IOP was normal and gonioscopy showed iridocorneal angle dysgenesis with prominent ciliary processes. Congenital microcoria is due to poor development of the iris dilator muscle of genetic cause. Early diagnosis and continuous follow-up for possible complications such as amblyopia, progressive myopia and juvenile glaucoma is essential. Since the diagnoses of glaucoma described in the literature were mainly made in individuals between 20-30 years old.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 8","pages":"Pages 492-496"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coriorretinopatía pigmentaria por déficit de 3-hidroxiacil-CoA-deshidrogenasa de cadena larga (LCHAD): un caso clínico con seguimiento a largo plazo 缺乏3-羟基-辅酶a长链脱氢酶(LCHAD)引起的色素性科里视网膜病:一个长期随访的临床病例
Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-08-01 DOI: 10.1016/j.oftal.2025.04.003
N. Castro Casal, N. Olivier Pascual, R. Arroyo Castillo
{"title":"Coriorretinopatía pigmentaria por déficit de 3-hidroxiacil-CoA-deshidrogenasa de cadena larga (LCHAD): un caso clínico con seguimiento a largo plazo","authors":"N. Castro Casal,&nbsp;N. Olivier Pascual,&nbsp;R. Arroyo Castillo","doi":"10.1016/j.oftal.2025.04.003","DOIUrl":"10.1016/j.oftal.2025.04.003","url":null,"abstract":"<div><div>Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD) is a rare but severe genetic disorder that causes pigmentary chorioretinopathy. We present the case of a 20-year-old female patient diagnosed with LCHAD by neonatal screening with alteration of the retinal pigment epithelium (RPE) since the age of 3 years. Fundus examination showed a salt-and-pepper speckled granular pattern and diffuse peripheral chorioretinal atrophy. The patient is stable, visually asymptomatic and with good systemic control after more than 15 years of follow-up with retinography, optical coherence tomography (OCT), autofluorescence (FAF) and electroretinogram (ERG), essential for control. This case highlights the importance of early diagnosis and treatment to prevent decompensation and improve survival and progression.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 8","pages":"Pages 497-503"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Actualización en biotecnología oftalmológica. Técnicas de identificación de biomarcadores moleculares y genéticos 眼科生物技术的更新。分子和遗传生物标志物鉴定技术
Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-08-01 DOI: 10.1016/j.oftal.2025.04.001
E. Marín-Payá , L. Zanón-Moreno , I. Andrés-Blasco , J. Marín-Montiel , M.D. Pinazo-Durán , V. Zanón-Moreno
{"title":"Actualización en biotecnología oftalmológica. Técnicas de identificación de biomarcadores moleculares y genéticos","authors":"E. Marín-Payá ,&nbsp;L. Zanón-Moreno ,&nbsp;I. Andrés-Blasco ,&nbsp;J. Marín-Montiel ,&nbsp;M.D. Pinazo-Durán ,&nbsp;V. Zanón-Moreno","doi":"10.1016/j.oftal.2025.04.001","DOIUrl":"10.1016/j.oftal.2025.04.001","url":null,"abstract":"","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 8","pages":"Pages 441-443"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adaptación cultural y validación del cuestionario del Índice de Enfermedades de la Superficie Ocular (OSDI) en la población mexicana 在墨西哥人口中对眼表面疾病指数(OSDI)问卷进行文化调整和验证
Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-08-01 DOI: 10.1016/j.oftal.2024.12.010
N. Kahuam-López , J.G. Serrano-Robles , G.R. Vera-Duarte , J.R. Bermeo-Escalona , C.A. Müller-Morales , A. Ramirez-Miranda , A. Navas , E.O. Graue-Hernandez
{"title":"Adaptación cultural y validación del cuestionario del Índice de Enfermedades de la Superficie Ocular (OSDI) en la población mexicana","authors":"N. Kahuam-López ,&nbsp;J.G. Serrano-Robles ,&nbsp;G.R. Vera-Duarte ,&nbsp;J.R. Bermeo-Escalona ,&nbsp;C.A. Müller-Morales ,&nbsp;A. Ramirez-Miranda ,&nbsp;A. Navas ,&nbsp;E.O. Graue-Hernandez","doi":"10.1016/j.oftal.2024.12.010","DOIUrl":"10.1016/j.oftal.2024.12.010","url":null,"abstract":"<div><h3>Objective</h3><div>Translate, culturally adapt, and validate the Ocular Surface Disease Index (OSDI) into Spanish for the Mexican population.</div></div><div><h3>Methods</h3><div>To ensure fluency and comprehensibility, we employed the Crawford and INFLEZS indexes. The Content Validity Coefficient was used to assess coherence, relevance, clarity, and sufficiency. Internal consistency was evaluated using Cronbach's Alpha Coefficient.</div></div><div><h3>Results</h3><div>A total of 372 participants were included in the study (63.4%, women; age ranged from 17 to 86<!--> <!-->years). According to the INFLEZS readability index, symptom-related items achieved scores of 82.56, 72.69, 85.81, 73.24, and 74.24. Lifestyle-related items obtained scores of 71.39, 76.90, 58.27, and 72.56, while in the environmental domain, scores of 83.61, 74.03, and 58.93 were recorded. Using the Crawford index, symptom scores were 3.6, 4.6, 3.5, 4.1, and 3.8, lifestyle scores were 4.7, 4.1, 5.1, and 4.6, and environmental scores were 3.7, 4.4, and 5.7. The Cronbach's alpha coefficient was 0.868. Based on the scores from the OSDI questionnaire, patients were categorized as having no dry eye (n<!--> <!-->=<!--> <!-->129), mild dry eye (n<!--> <!-->=<!--> <!-->99), moderate (n<!--> <!-->=<!--> <!-->45), and severe dry eye (n<!--> <!-->=<!--> <!-->99).</div></div><div><h3>Conclusions</h3><div>This study developed and validated the Mexican version of the OSDI, while assessing its reliability and internal consistency. With this tool, ophthalmologists and researchers alike will be able to assess and monitor Mexican-Spanish-speaking patients with dry eye in their routine clinical practice and future research.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 8","pages":"Pages 444-451"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oclusión bilateral y simultánea de arterias retinianas en mujer con lupus eritematoso sistémico 患有系统性红斑狼疮的女性同时双侧视网膜动脉闭塞
Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-08-01 DOI: 10.1016/j.oftal.2025.01.012
V.M. Asensio-Sánchez
{"title":"Oclusión bilateral y simultánea de arterias retinianas en mujer con lupus eritematoso sistémico","authors":"V.M. Asensio-Sánchez","doi":"10.1016/j.oftal.2025.01.012","DOIUrl":"10.1016/j.oftal.2025.01.012","url":null,"abstract":"<div><div>Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect almost every organ. This article describes a middle-aged woman, previously diagnosed with untreated SLE, who during a severe SLE flare simultaneously presented with a superior nasal artery occlusion in the right eye and a central retinal artery occlusion (CRAO) in the left eye. Severe ocular complications, such as CRAO, can occur during an acute flare of the disease in previously asymptomatic SLE.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 8","pages":"Pages 473-475"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Imagen multimodal de la migración retiniana de perfluorocarbono líquido 全氟碳液体视网膜迁移的多模态成像
Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-08-01 DOI: 10.1016/j.oftal.2024.08.015
F.J. Valentín Bravo , K. Castaño Andrés , X. Valldeperas
{"title":"Imagen multimodal de la migración retiniana de perfluorocarbono líquido","authors":"F.J. Valentín Bravo ,&nbsp;K. Castaño Andrés ,&nbsp;X. Valldeperas","doi":"10.1016/j.oftal.2024.08.015","DOIUrl":"10.1016/j.oftal.2024.08.015","url":null,"abstract":"","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 8","pages":"Pages 508-509"},"PeriodicalIF":0.0,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluación de la efectividad del implante de válvula de Ahmed adicionando mitomicina C en pacientes con glaucoma refractario a un año de seguimiento 对Ahmed添加肌霉素C瓣膜植入物对难治性青光眼患者一年随访的有效性的评价
Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-07-28 DOI: 10.1016/j.oftal.2025.06.003
O. Teherán , C. Parra , E. Ramos , M. Ochoa , W. Escobar
{"title":"Evaluación de la efectividad del implante de válvula de Ahmed adicionando mitomicina C en pacientes con glaucoma refractario a un año de seguimiento","authors":"O. Teherán ,&nbsp;C. Parra ,&nbsp;E. Ramos ,&nbsp;M. Ochoa ,&nbsp;W. Escobar","doi":"10.1016/j.oftal.2025.06.003","DOIUrl":"10.1016/j.oftal.2025.06.003","url":null,"abstract":"<div><h3>Introduction</h3><div>The Ahmed valve is indicated for glaucoma refractory to maximal pharmacologic therapy and properly performed filtering surgeries. Surgical success can be compromised by the formation of fibrotic tissue around the valve body; various strategies have been employed to prevent this, including the use of antimetabolites such as mitomycin C (MMC).</div></div><div><h3>Aim</h3><div>To evaluate the effectiveness and safety of mitomycin C (MMC) use when implanting Ahmed valve in patients with refractory glaucoma.</div></div><div><h3>Methods</h3><div>Cohort study involving 34 patients divided into 2 groups of 17 patients each: group 1 (MMC use) and group 2 (no MMC use), with a one-year follow-up. Complete success was defined as intraocular pressure (IOP) between 6-18<!--> <!-->mmHg without the use of antiglaucoma medications; qualified success referred to the same IOP range but associated with antiglaucoma medications, while failure was characterized by IOP outside this range, severe complications or reintervention.</div></div><div><h3>Results</h3><div>The overall success rate in group 1 was 88.2%, and in group 2, 94.2%. There was an average reduction in IOP of 18.0<!--> <!-->±<!--> <!-->11.5<!--> <!-->mmHg in group 1 and 11.3<!--> <!-->±<!--> <!-->5.0<!--> <!-->mmHg in group 2 (p<!--> <!-->=<!--> <!-->0.0352). The hypertensive phase occurred in 17.6% of the participants in the first group and the second, 70.6% (p<!--> <!-->=<!--> <!-->0.0048).</div></div><div><h3>Conclusions</h3><div>The use of MMC decreases the hypertensive phase observed in Ahmed valve implant surgery, thereby achieving better IOP control.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 9","pages":"Pages 521-527"},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144913849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nuevos sistemas biotecnológicos de administración de fármacos para la degeneración macular asociada a la edad 为老年性黄斑变性提供药物的新生物技术系统
Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-07-25 DOI: 10.1016/j.oftal.2025.03.009
S. Amatha , R. Das , M.K. Gautam , S. Mondal
{"title":"Nuevos sistemas biotecnológicos de administración de fármacos para la degeneración macular asociada a la edad","authors":"S. Amatha ,&nbsp;R. Das ,&nbsp;M.K. Gautam ,&nbsp;S. Mondal","doi":"10.1016/j.oftal.2025.03.009","DOIUrl":"10.1016/j.oftal.2025.03.009","url":null,"abstract":"<div><div>Recent years have witnessed remarkable advancements in biotechnological ocular drug delivery systems, introducing novel strategies such as gene therapy, cell-based systems, and targeted carriers. This article focuses specifically on age-related macular degeneration, the most prevalent ocular condition. While gene therapy holds promise for age-related macular degeneration treatment, it also presents significant challenges, leading to the exploration of cell-based therapy as a complementary or alternative approach. To address these hurdles and ensure successful market translation, new companies often form collaborative expert teams encompassing all relevant fields, including regulatory affairs. As medical science continues to evolve, a comprehensive understanding of gene therapy, cell-based delivery, biocompatibility, safety considerations, regulatory aspects, and ongoing clinical trials is essential to fully grasp the safety and effectiveness of these novel ocular therapies. Consequently, this paper primarily explores these key areas. The successful evolution of biotechnological ocular delivery signals a positive shift towards personalized medicine, which is expected to significantly improve the quality of life for age-related macular degeneration patients in the near future.</div></div>","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 9","pages":"Pages 537-548"},"PeriodicalIF":0.0,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144912388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Éxito quirúrgico en el desprendimiento de retina regmatógeno: nuevas consideraciones en 2025 手术成功切除regmatorgenos视网膜:2025年的新考虑因素
Archivos De La Sociedad Espanola De Oftalmologia Pub Date : 2025-07-25 DOI: 10.1016/j.oftal.2025.06.001
L. López Guajardo , P. Carnota Méndez , F. González del Valle
{"title":"Éxito quirúrgico en el desprendimiento de retina regmatógeno: nuevas consideraciones en 2025","authors":"L. López Guajardo ,&nbsp;P. Carnota Méndez ,&nbsp;F. González del Valle","doi":"10.1016/j.oftal.2025.06.001","DOIUrl":"10.1016/j.oftal.2025.06.001","url":null,"abstract":"","PeriodicalId":8348,"journal":{"name":"Archivos De La Sociedad Espanola De Oftalmologia","volume":"100 9","pages":"Pages 511-513"},"PeriodicalIF":0.0,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144913899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信